Anson Lowe
Academic Appointments
- Associate Professor, Medicine - Gastroenterology & Hepatology
- Member, Stanford Cancer Institute
- Associate Professor (By courtesy), Molecular & Cellular Physiology
Key Documents
Contact Information
-
Clinical Offices
Gastroenterology Clinic 900 Blake Wilbur Dr Garden Level MC 5355 Palo Alto, CA 94304 Tel Work (650) 736-5555 Fax (650) 498-6323
- Academic Offices
Personal Information Email Tel (650) 725-3372 Tel (650) 725-6764Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Gastroenterology
- Pancreatic diseases
Administrative Appointments
- Associate Director, Stanford Digestive Disease Center, Stanford University (2001 - 2012)
- Co-Director, Stanford Gastroenterology Training Program, Stanford University (2012 - present)
- Special Sections Editor, Gastroenterology (journal) (2011 - present)
- Associate Editor, The American Journal of Medicine (2000 - 2004)
- Member, Stanford School of Medicine Awards Committee, Stanford University (2001 - present)
- Co-Course Director - Human Health & Disease, Stanford University (2004 - present)
Honors and Awards
- Lester R. Tuchman Award for clinical excellence (graduating class award), Mount Sinai Hospital (1980)
- AOA inductee, Alpha Omega Alpha Honor Medical Society (1979)
- Division Teaching Award, Stanford University (2001, 2004, 2007, 2008, 2012)
Professional Education
| Residency: | Presbyterian Hospital NY (1983) |
| Board Certification: | Gastroenterology, American Board of Internal Medicine (1987) |
| Fellowship: | UCSF Medical Center CA (1989) |
| Fellowship: | Columbia University School of Public Health NY (1984) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1983) |
| Internship: | Presbyterian Hospital NY (1981) |
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
Our laboratory is focused on the development of adenocarcinomas, which account for the majority of human solid tumors that result in death. In particular, we have focused on the gene AGR2, which is expressed in all adenocarcinomas and supports many of the features displayed by tumors. Active projects include pancreatic, esophageal, colon, and lung adenocarcinomas. Our work not only includes how adenocarcinomas develop, but also their diagnosis and treatment. We have recently developed several clinical assays for the diagnosis of pancreatic diseases.
Publications
- CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth. Cancer. 2013; (6): 1217-26
- Loss of anterior gradient 2 (Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach. J Biol Chem. 2013; (6): 4321-33
- Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. Gastrointest Endosc. 2013
- AGR2 gene function requires a unique endoplasmic reticulum localization motif. J Biol Chem. 2012; (7): 4773-82
- Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts. BMC Gastroenterol. 2012: 15
- Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping. Hum Pathol. 2012; (11): 1799-807
Help